Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Bibliografische gegevens
Hoofdauteurs:	Xu, S, Scott, C, Coleman, RL, Tuomilehto, J, Holman, RR
Formaat:	Conference item
Taal:	English
Gepubliceerd in:	Springer Nature 2019

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
door: Xu, S, et al.
Gepubliceerd in: (2021)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
door: Wamil, M, et al.
Gepubliceerd in: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
door: Leal, J, et al.
Gepubliceerd in: (2022)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
door: Holman, R, et al.
Gepubliceerd in: (2017)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
door: Currie, G, et al.
Gepubliceerd in: (2017)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
door: Wamil, M, et al.
Gepubliceerd in: (2020)

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
door: Liam Mc Morrow, et al.
Gepubliceerd in: (2024-02-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
door: Nihar Ranjan Mohanty, et al.
Gepubliceerd in: (2022-06-01)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
door: Wamil, M, et al.
Gepubliceerd in: (2021)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
door: Califf, R, et al.
Gepubliceerd in: (2003)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
door: Califf, R, et al.
Gepubliceerd in: (2008)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
door: Anke Tönjes, et al.
Gepubliceerd in: (2010-01-01)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
door: Yates, T, et al.
Gepubliceerd in: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
door: Yates, T, et al.
Gepubliceerd in: (2014)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
door: Stevens, R, et al.
Gepubliceerd in: (2005)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
door: Gerstein, H, et al.
Gepubliceerd in: (2006)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
door: Susanne Andersson, et al.
Gepubliceerd in: (2011-01-01)

Florid diabetic complications in impaired glucose tolerance
door: Anil P Bhatt, et al.
Gepubliceerd in: (2013-01-01)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
door: Farrer, M, et al.
Gepubliceerd in: (1993)

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
door: Holman, R, et al.
Gepubliceerd in: (1979)

Oxidative injury and neuropathy in diabetes and impaired glucose tolerance
door: James W. Russell, et al.
Gepubliceerd in: (2008-06-01)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
door: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Gepubliceerd in: (2012-01-01)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
door: Mostafa, SA, et al.
Gepubliceerd in: (2017)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
door: Preiss, D, et al.
Gepubliceerd in: (2013)

FASTING BLOOD-GLUCOSE CONCENTRATIONS AND TREATMENT OF MATURITY-ONSET DIABETES
door: Howedavies, S, et al.
Gepubliceerd in: (1980)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
door: Holman, R
Gepubliceerd in: (1996)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
door: Yutaka Inoue, et al.
Gepubliceerd in: (2022-06-01)

Identification of Significant Predictors for the Need of Insulin Therapy and Onset of Postpartum Impaired Glucose Tolerance in Gestational Diabetes Mellitus Patients
door: Wang T, et al.
Gepubliceerd in: (2021-06-01)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
door: Yupu Liu, et al.
Gepubliceerd in: (2022-02-01)

Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
door: Hermans, M, et al.
Gepubliceerd in: (1996)

New-onset diabetes after transplantation and oral glucose tolerance test
door: Somsri Wiwanitkit, et al.
Gepubliceerd in: (2014-01-01)

The basal plasma glucose: a simple relevant index of maturity-onset diabetes.
door: Holman, R, et al.
Gepubliceerd in: (1981)

CONTROL OF MATURITY-ONSET DIABETES BY HOME OR CLINIC MONITORING OF FASTING PLASMA GLUCOSE
door: Howedavies, S, et al.
Gepubliceerd in: (1978)

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes
door: Agbaje, O, et al.
Gepubliceerd in: (2017)

Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
door: Ursula Mager, et al.
Gepubliceerd in: (2008-08-01)

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study
door: Xin Zhang, et al.
Gepubliceerd in: (2023-01-01)

Dyslipidemia, metabolic syndrome, and liver enzymes in impaired glucose tolerance and new onset untreated, type 2 diabetes Indian subjects
door: Debmalaya Sanyal, et al.
Gepubliceerd in: (2012-01-01)

Coronary heart disease incidence and mortality, and all-cause mortality among diabetic and non-diabetic people according to their smoking behavior in Finland
door: Noël C. Barengo, et al.
Gepubliceerd in: (2017-02-01)

Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes.
door: McLellan, J, et al.
Gepubliceerd in: (1995)

Associations of green tea and rock tea consumption with risk of impaired fasting glucose and impaired glucose tolerance in Chinese men and women.
door: Huibin Huang, et al.
Gepubliceerd in: (2013-01-01)

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Gelijkaardige items

Gelijkaardige items